Drug Delivery

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301

Here’s why virus-like particles could open a new chapter in combating disease.

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

We need non-opioid options for pain relief. Paradigm Biopharmaceuticals discuss their studies into a new option for osteoarthritis patients

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

TUM Researchers create organoid that emulates the development of the human heart

Researchers identify brain pathway – miR483-5p/Pgap2 – that holds promise for future anxiety treatments

Improved mutational understanding may help develop therapeutics against antimicrobial resistance

Swedish researchers target the brain’s reward system to treat alcohol use disorder